Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 68 | 2026 | 2586 | 7.670 |
Why?
|
| Residence Characteristics | 17 | 2022 | 363 | 3.350 |
Why?
|
| Florida | 53 | 2026 | 478 | 3.260 |
Why?
|
| Anti-HIV Agents | 16 | 2025 | 486 | 3.180 |
Why?
|
| Emigrants and Immigrants | 12 | 2021 | 158 | 3.110 |
Why?
|
| Homosexuality, Male | 10 | 2025 | 486 | 2.360 |
Why?
|
| Viral Load | 19 | 2025 | 348 | 2.360 |
Why?
|
| Healthcare Disparities | 11 | 2023 | 590 | 1.990 |
Why?
|
| Continuity of Patient Care | 7 | 2020 | 120 | 1.730 |
Why?
|
| Medication Adherence | 8 | 2025 | 182 | 1.600 |
Why?
|
| Delayed Diagnosis | 6 | 2018 | 38 | 1.470 |
Why?
|
| Substance-Related Disorders | 5 | 2022 | 830 | 1.240 |
Why?
|
| Adolescent | 35 | 2025 | 6081 | 1.200 |
Why?
|
| Adult | 54 | 2026 | 13872 | 1.200 |
Why?
|
| Young Adult | 36 | 2026 | 5080 | 1.170 |
Why?
|
| Humans | 83 | 2026 | 43102 | 1.150 |
Why?
|
| Substance Abuse, Intravenous | 3 | 2020 | 129 | 1.010 |
Why?
|
| Mass Screening | 5 | 2019 | 541 | 0.990 |
Why?
|
| Male | 52 | 2026 | 23409 | 0.990 |
Why?
|
| Risk Factors | 18 | 2022 | 3994 | 0.930 |
Why?
|
| Middle Aged | 35 | 2026 | 12222 | 0.870 |
Why?
|
| Minority Groups | 8 | 2025 | 690 | 0.820 |
Why?
|
| Female | 53 | 2026 | 24698 | 0.810 |
Why?
|
| Anomie | 2 | 2021 | 6 | 0.790 |
Why?
|
| Health Status Disparities | 5 | 2026 | 719 | 0.740 |
Why?
|
| Population Surveillance | 4 | 2019 | 246 | 0.690 |
Why?
|
| Rural Population | 9 | 2026 | 373 | 0.660 |
Why?
|
| Mental Health | 3 | 2025 | 385 | 0.590 |
Why?
|
| Drug Users | 1 | 2019 | 52 | 0.580 |
Why?
|
| United States | 15 | 2024 | 5205 | 0.550 |
Why?
|
| Unsafe Sex | 1 | 2019 | 162 | 0.540 |
Why?
|
| Criminals | 1 | 2017 | 18 | 0.520 |
Why?
|
| Chlamydia Infections | 1 | 2019 | 200 | 0.520 |
Why?
|
| Socioeconomic Factors | 8 | 2024 | 1234 | 0.500 |
Why?
|
| Self Efficacy | 3 | 2025 | 215 | 0.490 |
Why?
|
| Urban Population | 6 | 2021 | 374 | 0.490 |
Why?
|
| Professional-Patient Relations | 3 | 2025 | 60 | 0.490 |
Why?
|
| Secondary Prevention | 1 | 2014 | 48 | 0.440 |
Why?
|
| Primary Prevention | 1 | 2014 | 63 | 0.430 |
Why?
|
| HIV Seropositivity | 1 | 2015 | 196 | 0.410 |
Why?
|
| Haiti | 8 | 2025 | 86 | 0.400 |
Why?
|
| Odds Ratio | 5 | 2017 | 587 | 0.390 |
Why?
|
| Mexican Americans | 1 | 2015 | 226 | 0.390 |
Why?
|
| Anti-Retroviral Agents | 6 | 2023 | 160 | 0.380 |
Why?
|
| Cross-Sectional Studies | 13 | 2025 | 3156 | 0.370 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2025 | 497 | 0.370 |
Why?
|
| Retrospective Studies | 8 | 2024 | 2544 | 0.350 |
Why?
|
| Premature Birth | 2 | 2022 | 95 | 0.330 |
Why?
|
| Mexico | 3 | 2017 | 298 | 0.320 |
Why?
|
| Social Support | 3 | 2025 | 445 | 0.320 |
Why?
|
| Poverty | 4 | 2024 | 400 | 0.310 |
Why?
|
| Depression | 3 | 2025 | 863 | 0.310 |
Why?
|
| Bayes Theorem | 2 | 2024 | 126 | 0.300 |
Why?
|
| Cuba | 2 | 2019 | 33 | 0.290 |
Why?
|
| Sex Factors | 4 | 2026 | 1028 | 0.290 |
Why?
|
| Demography | 2 | 2019 | 195 | 0.290 |
Why?
|
| Logistic Models | 5 | 2018 | 1009 | 0.280 |
Why?
|
| Prevalence | 5 | 2021 | 1612 | 0.280 |
Why?
|
| South America | 2 | 2019 | 24 | 0.260 |
Why?
|
| Stress, Psychological | 3 | 2025 | 661 | 0.250 |
Why?
|
| Trust | 2 | 2025 | 167 | 0.240 |
Why?
|
| Reproducibility of Results | 4 | 2024 | 1081 | 0.240 |
Why?
|
| Central America | 2 | 2017 | 13 | 0.240 |
Why?
|
| Rural Health | 2 | 2016 | 55 | 0.220 |
Why?
|
| Alcohol Drinking | 2 | 2023 | 609 | 0.220 |
Why?
|
| Physician-Patient Relations | 1 | 2025 | 148 | 0.210 |
Why?
|
| Incidence | 3 | 2020 | 1078 | 0.210 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2024 | 226 | 0.210 |
Why?
|
| Puerto Rico | 3 | 2018 | 1413 | 0.200 |
Why?
|
| Qualitative Research | 3 | 2025 | 574 | 0.200 |
Why?
|
| Patient-Centered Care | 1 | 2024 | 75 | 0.200 |
Why?
|
| Psychometrics | 2 | 2024 | 358 | 0.190 |
Why?
|
| Cause of Death | 3 | 2026 | 186 | 0.190 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1723 | 0.180 |
Why?
|
| Aged | 6 | 2020 | 8214 | 0.180 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 2853 | 0.170 |
Why?
|
| Adaptation, Physiological | 2 | 2020 | 143 | 0.170 |
Why?
|
| Career Mobility | 1 | 2021 | 29 | 0.170 |
Why?
|
| Vaginosis, Bacterial | 1 | 2020 | 8 | 0.170 |
Why?
|
| Sexual Behavior | 3 | 2020 | 638 | 0.170 |
Why?
|
| Pregnancy Complications | 1 | 2022 | 140 | 0.170 |
Why?
|
| Motivation | 1 | 2025 | 513 | 0.170 |
Why?
|
| Metronidazole | 1 | 2020 | 16 | 0.170 |
Why?
|
| Gonorrhea | 1 | 2021 | 24 | 0.170 |
Why?
|
| Anxiety | 2 | 2021 | 874 | 0.170 |
Why?
|
| Chlamydia | 1 | 2021 | 45 | 0.170 |
Why?
|
| Faculty, Medical | 1 | 2021 | 74 | 0.160 |
Why?
|
| Prenatal Care | 2 | 2022 | 93 | 0.160 |
Why?
|
| Triage | 1 | 2020 | 34 | 0.160 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 56 | 0.150 |
Why?
|
| Philadelphia | 1 | 2019 | 20 | 0.150 |
Why?
|
| Research Personnel | 1 | 2021 | 206 | 0.150 |
Why?
|
| Students | 1 | 2025 | 626 | 0.150 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2020 | 229 | 0.150 |
Why?
|
| Intention | 1 | 2020 | 108 | 0.150 |
Why?
|
| Geographic Information Systems | 1 | 2019 | 47 | 0.140 |
Why?
|
| Program Evaluation | 1 | 2020 | 359 | 0.140 |
Why?
|
| Patient Compliance | 1 | 2020 | 233 | 0.140 |
Why?
|
| Case Management | 1 | 2018 | 24 | 0.140 |
Why?
|
| Acculturation | 1 | 2020 | 205 | 0.140 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 518 | 0.130 |
Why?
|
| Cohort Studies | 5 | 2021 | 1759 | 0.130 |
Why?
|
| Health Personnel | 1 | 2020 | 277 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 310 | 0.130 |
Why?
|
| Age Factors | 1 | 2020 | 1154 | 0.130 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2017 | 74 | 0.120 |
Why?
|
| Cognition | 1 | 2020 | 473 | 0.120 |
Why?
|
| Risk-Taking | 2 | 2020 | 457 | 0.120 |
Why?
|
| Urban Health | 1 | 2016 | 101 | 0.120 |
Why?
|
| Death Certificates | 1 | 2015 | 15 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2021 | 502 | 0.120 |
Why?
|
| Alcohol-Related Disorders | 1 | 2016 | 63 | 0.110 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2017 | 117 | 0.110 |
Why?
|
| Caribbean Region | 3 | 2021 | 79 | 0.110 |
Why?
|
| Time Factors | 1 | 2019 | 1857 | 0.110 |
Why?
|
| Marriage | 1 | 2014 | 21 | 0.110 |
Why?
|
| Infant, Newborn | 3 | 2022 | 972 | 0.100 |
Why?
|
| SEER Program | 1 | 2014 | 164 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2014 | 195 | 0.100 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 449 | 0.090 |
Why?
|
| Parenting | 1 | 2014 | 137 | 0.090 |
Why?
|
| Vaccination | 2 | 2025 | 355 | 0.090 |
Why?
|
| Pregnancy | 3 | 2022 | 1772 | 0.080 |
Why?
|
| Algorithms | 1 | 2014 | 509 | 0.080 |
Why?
|
| Safe Sex | 2 | 2021 | 78 | 0.080 |
Why?
|
| Quality of Life | 1 | 2014 | 616 | 0.070 |
Why?
|
| Infant | 2 | 2022 | 1175 | 0.070 |
Why?
|
| Health Services Accessibility | 3 | 2020 | 706 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2022 | 1600 | 0.070 |
Why?
|
| Sexual Partners | 2 | 2021 | 326 | 0.070 |
Why?
|
| Neoplasms | 1 | 2017 | 1377 | 0.060 |
Why?
|
| Anger | 1 | 2025 | 27 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2024 | 111 | 0.050 |
Why?
|
| Self Concept | 1 | 2025 | 171 | 0.050 |
Why?
|
| Disclosure | 1 | 2023 | 39 | 0.050 |
Why?
|
| Canada | 1 | 2023 | 163 | 0.050 |
Why?
|
| Texas | 1 | 2025 | 457 | 0.050 |
Why?
|
| Diethylstilbestrol | 1 | 2023 | 11 | 0.050 |
Why?
|
| India | 1 | 2022 | 108 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 1 | 2022 | 36 | 0.050 |
Why?
|
| Housing | 1 | 2022 | 74 | 0.040 |
Why?
|
| Latin America | 1 | 2021 | 55 | 0.040 |
Why?
|
| Universities | 1 | 2025 | 559 | 0.040 |
Why?
|
| Birth Weight | 1 | 2022 | 95 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 41 | 0.040 |
Why?
|
| Emigration and Immigration | 1 | 2021 | 85 | 0.040 |
Why?
|
| Recurrence | 1 | 2020 | 152 | 0.040 |
Why?
|
| AIDS Serodiagnosis | 1 | 2020 | 25 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2022 | 258 | 0.040 |
Why?
|
| Population Density | 1 | 2020 | 38 | 0.040 |
Why?
|
| Financing, Government | 1 | 2020 | 20 | 0.040 |
Why?
|
| Drug Monitoring | 1 | 2020 | 69 | 0.040 |
Why?
|
| Prejudice | 1 | 2020 | 116 | 0.040 |
Why?
|
| Paris | 1 | 2019 | 2 | 0.040 |
Why?
|
| France | 1 | 2019 | 23 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 375 | 0.040 |
Why?
|
| Community-Institutional Relations | 1 | 2021 | 219 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 440 | 0.040 |
Why?
|
| Multilevel Analysis | 1 | 2018 | 21 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 231 | 0.030 |
Why?
|
| Vital Statistics | 1 | 2017 | 7 | 0.030 |
Why?
|
| Individuality | 1 | 2018 | 54 | 0.030 |
Why?
|
| Emotions | 1 | 2020 | 254 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1063 | 0.030 |
Why?
|
| Health Services Misuse | 1 | 2017 | 20 | 0.030 |
Why?
|
| Causality | 1 | 2016 | 45 | 0.030 |
Why?
|
| Social Class | 1 | 2018 | 291 | 0.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2015 | 44 | 0.030 |
Why?
|
| Boston | 1 | 2014 | 32 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2014 | 76 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 224 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 737 | 0.020 |
Why?
|
| Heterosexuality | 1 | 2014 | 97 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2014 | 452 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 222 | 0.020 |
Why?
|